WO2017216818A1 - Anaerobic growth of bacteria in unicellular alga - Google Patents

Anaerobic growth of bacteria in unicellular alga Download PDF

Info

Publication number
WO2017216818A1
WO2017216818A1 PCT/IT2016/000158 IT2016000158W WO2017216818A1 WO 2017216818 A1 WO2017216818 A1 WO 2017216818A1 IT 2016000158 W IT2016000158 W IT 2016000158W WO 2017216818 A1 WO2017216818 A1 WO 2017216818A1
Authority
WO
WIPO (PCT)
Prior art keywords
culture
extract
anaerobic
growth
unicellular
Prior art date
Application number
PCT/IT2016/000158
Other languages
French (fr)
Inventor
Beatrice LETER
Raffaella BRUSCHI
Original Assignee
Ocean Farma Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ocean Farma Srl filed Critical Ocean Farma Srl
Priority to PCT/IT2016/000158 priority Critical patent/WO2017216818A1/en
Publication of WO2017216818A1 publication Critical patent/WO2017216818A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02Algae

Definitions

  • the present invention relates to a novel method for microbiological culture. More particularly, the present invention relates to a method of culture of a probiotic anaerobic bacterium, both obligate and facultative in unicellular algae, with a high nutritional value for human supply, in particular rich in omega-3.
  • probiotics based on different bacterial strains are available on the market (generally Lactobacilli or Bifidobacteria) .
  • These probiotics produce lactic acid by fermentation of sugars, in different formulations and concentrations.
  • the beneficial properties of lactic acid are widely recognized, some closely related with bowel health, through the edit action of the intestinal flora.
  • fermented foods e.g. Yogurt, cheese
  • nutritional qualities of different unicellular algae e.g. Spirulina, Chlorella, Dunaniella
  • Spirulina e.g. Spirulina, Chlorella, Dunaniella
  • These algae are rich in protein, minerals and trace elements and they are already greatly appreciated as supplements in the human diet.
  • omega-3 polyunsaturated fatty acids
  • the present invention aims to provide a product that combines the beneficial properties of probiotics and the ones of unicellular algae rich in omega-3 fatty acids. Specifically, the present invention arises the purpose of providing a product based on probiotic strains grown in unicellular algae rich in omega - 3 which combines the beneficial properties of the cultivated probiotics with the omega - 3 fatty acids .
  • the present invention aims to provide a product suitable to constitute the source of probiotic bacteria grown under anaerobic conditions (fermentation) in a culture medium, based on unicellular algae rich in omega - 3, which is suitable for the growing of bacterial strains and, at the end of the bacterial culture, it must not be removed because it provides an important contribution to the human diet, as a source of omega - 3.
  • this preparation has nutritional value (since the probiotic, during the fermentation time, consumes the glucose component of a unicellular alga, leaving unchanged the lipid portion rich in omega-3 available to the human consumption) and therapeutic (both the curative effects of the probiotic and the anti inflammatory and anti - oxidant of the omega - 3 are known) and cosmetic properties (different probiotic strains produce metabolites of glycerin and other moisturizing , ions and heavy metals, where ⁇ bacterial metabolite ' means any molecule of neo-synthesis that is metabolized by a bacterium, which is economically interesting and obtained by anaerobic growth) .
  • an homogenized unicellular microalgae is accessible from a bacterium, which is able to grow inside it in anaerobic conditions.
  • a method of culture of an anaerobic bacterium both obligate or facultative which is inoculated in a homogenised or entire extract of unicellular microalgae in a solvent under anaerobic conditions; the unicellular microalgae has a concentration in the solvent able to sustain the growth of the anaerobic bacteria.
  • the present invention possibly involves the further addition of a complement of sugar to the extract of unicellular microalgae in the method of culture of the anaerobic bacteria.
  • the method presented in this invention is economically advantageous and useful for the activation of the metabolism of the anaerobic bacterium and for its tropism in the intestinal lumen.
  • the method makes superfluous each subsequent purification step of the bacterium from its growth medium, which in turn has an important nutritional value in the lipid content and therapeutic properties due to the presence of omega - 3.
  • the approach of the present invention does not contain any extraction of the organic phase or enrichment of the lipid phase.
  • the microalga is used in its entirety, since the component of sugar and protein is functional to the growth of the bacterium, while the lipid portion is maintained as a source of omega - 3 fatty acids in the final fermented product .
  • the extract of single-cell microalgae is an extract of Nannochloropsis gaditana homogenized and, in particular, that the extract of Nannochloropsis gaditana has been obtained starting from a fresh culture of Nannochloropsis gaditana in the exponential phase of growth.
  • the single- cell microalgae extract is an extract of Isochrysis sp. And, more particularly, that the extract of Isochrysis sp. has been obtained from Isochrysis sp. lyophilized.
  • a product containing a fermented is so obtained, comprising in combination both a bacterial culture medium and a bacterial population grown in it, obtained by the method of culture of an anaerobic bacterium as described above, for which the product is suitable as source of probiotic and simultaneously as source of a fermented of the unicellular alga containing omega- 3 for nutritional, therapeutic or cosmetic use.
  • Lactobacillus sp. is the inoculated anaerobic bacterium.
  • a product containing an entire fermented is so obtained as described above, wherein the anaerobic bacterium is Lactobacillus sp., for which the product is suitable as a source of probiotic and, at the same time, as a dietary supplement of the fermented of algae, rich in omega - 3, used for the growth of the bacterium.
  • the present invention defines a culture technique of obligate or facultative anaerobic bacteria, which does not resort to the microbiological culture media available on the market, and uses an entire or homogenate extract of single-cell microalgae in oxygen-free conditions as the sole source of proliferation of the bacteria.
  • the fermented product obtained with the method of the present invention is completely free of animal elements, respect to probiotics grown in classical culture broths, containing extracts of lean meat, rich in amino acids, peptides, nucleotides, organic acids, vitamins and minerals. Therefore, a method of culture of an anaerobic bacterium, obligate or facultative, as recited in Claim 1 attached hereto, constitutes the object of the present invention.
  • object of the present invention is also a method of culture of an anaerobic bacterium, obligate or facultative, as recited in Claim 2 attached hereto. Preferred examples of this method are recited in the dependent claims 3; 4; 5 ; 6, e 7. Object of the present invention is also a product containing an entire fermented, comprising in combination both a medium of bacterial culture and a bacterial population grown in it, as recited in the attached claim 8. A preferred example of this method is recited in the attached dependent claims 9.
  • the present invention will be fully understood based on the following detailed description of the best way of implementing it, given only as example, absolutely not limitative of the invention itself, in reference to the attached drawings, in which:
  • FIG 1 is a diagram which shows the curves of bacterial growth under anaerobic conditions in an extract of a first strain of the unicellular alga in a bacterial culture according to the method of the present invention and in a culture media commercially available, and
  • FIGURE 2 is a diagram showing the curves of bacterial growth under anaerobic conditions in an extract of a second strain of the unicellular alga in a bacterial culture according to the method of the present invention and in a culture medium commercially available.
  • the present invention is a method of culture of an anaerobic bacterium, obligate or facultative, that inoculates anaerobic bacteria in a homogenate or entire extract of the unicellular alga in a solvent under anaerobic conditions.
  • concentration of the unicellular alga in the solvent has to be effective to sustain the growth of anaerobic bacteria.
  • the extract of unicellular algae is an homogenized extract of Nannochloropsis gaditana and the anaerobic bacterium, from the strain Lactobacillus sp..
  • Nannochloropsis gaditana is a spheroidal microalgae of diameter about 2 - 3 micrometers, devoid of motor structures. Its lipid content is about 30% of its dry weight. It accumulates large concentrations of various pigments, such as, for example, astaxanthin, canthaxanthin and zeaxanthin. Nannochloropsis gaditana is also a food product and, indeed, it is used to produce dietary- supplements. It is also served at the restaurant in Spain in El Puerto de Santa Maria in Cadiz, in the area where it was isolated for the first time and where it still grows wild.
  • Nannochloropsis gaditana the bioavailable sugars were measured in the laboratory by the Inventors and result to be dependent on the lysis method of microalgae and constitute from 4 % to 8 % of microalgae dry mass, distributed as follows: from 40% to 50 % of glucose; from 18% to 23 % of galactose; from 13% to from 2% to 4 % of xylose ; from 3% to 5 % of ribose ; from 4 % to 8 % other sugars .
  • the extract Nannochloropsis gaditana may have been obtained from a fresh culture of Nannochloropsis gaditana in exponential phase of growth, and the micro-algae of the strain of Nannochloropsis gaditana was subjected to a mechanical homogenization process via a probe homogenizer with teflon head, by homogenization of 2 minutes at 14,000 rounds per minute.
  • the parameter for the choice of the concentration of microalgae in physiological saline solution was determined based on obtaining an amount of sugar comparable with that described in the literature as sufficient to maintain fermentative metabolism of Lactobacillus sp., that is 10 grams per liter. In order to not compromise the isotonicity of the culture medium, the amount of 100 grams of dry mass per liter of physiological solution it was never exceeded.
  • the concentration of extract of Nannochloropsis gaditana was less than 10 grams per litre. With this dilution the Inventors verified the growth with the extract of algae, but also with an addition of a complement of 5 grams of glucose per liter and with a culture medium MRS DE MAN - ROGOSA - SHARPE for lactobacilli , commercially available. In the exposed experiment a sterility control of the culture medium and of the extract of microalgae was included. Under the experimental conditions of Example I, the growth took place into sealed tubes, in fact, any induced correction of the acidity produced by lactic acid fermentation was not expected, it was therefore expected that the fermentation was stopped because of the acidification of the culture medium and because of sugar depletion.
  • FIGURE 1 The results of the growth of Lactobacillus sp. in the extract of Nannochloropsis gaditana, fresh and homogenized, are illustrated in FIGURE 1, in which: the curve 1 is the growth curve obtained with the commercially available MRS culture medium; the curve 2 is the growth curve of Lactobacillus sp. in the extract of Nannochloropsis gaditana (homogenized) ; curve 3 is the growth curve of Lactobacillus sp. in the extract of Nannochloropsis gaditana (homogenized) with the addition of 5 grams of glucose per liter of physiological solution.
  • the inventors revealed that, in the aforementioned experimental conditions, the suitably homogenized extract of Nannochloropsis gaditana was able to support the growth of Lactobacillus sp. without the aid of any sugar integration, even if an addition of sugar sensibly improves the yield, at least for three days starting from the inoculation of the bacterium.
  • the extract of unicellular microalgae is an extract of Isochrysis sp. and the strain of the anaerobic bacterium is Lactobacillus sp..
  • Isochrysis sp. is a brown and flagellated unicellular alga, about 5 micrometers long and widely used in aquaculture. It has a high content of docosahexaenoic acid or DHA (omega - 3 fatty acid is the most effectively under the curative profile) and Isochrysis sp. is often used to enrich zooplankton (rotifers or Artemia) .
  • Isochrysis sp. The high content of omega3 and sugar (about 30% of the dry weight) of Isochrysis sp., in addition to the absence of a cellulose capsule, makes Isochrysis sp. particularly suitable for the purposes of the present invention.
  • the advantage of Isochrysis sp. is to have a high content of sugars and not to possess a cellulose capsule. This latter feature ensures that it is accessible to a bacterium and that is able to ensure the growth also in a non-homogenized state.
  • Example II the extract of Isochrysis sp. was obtained from Isochrysis sp. lyophilized. Even under the experimental conditions of Example II the growth took place in sealed tubes in such a way that the application of any induced correction of acidity produced by lactic acid fermentation was not expected. It was therefore expected that the fermentation was stopped by the acidification of the culture medium and cause of sugar depletion.
  • FIGURE 2 The results of the growth of Lactobacillus sp. in Isochrysis sp . extract are illustrated in FIGURE 2, in which: the curve 11 is the growth curve obtained with the commercially available MRS culture medium; the curve 12 is the growth curve of Lactobacillus sp. in the entire extract of Isochrysis sp.; the curve 13 is the growth curve of Lactobacillus sp. in the entire extract of Isochrysis sp., with the addition of 5 grams of glucose per litre of physiological solution; the curve 14 is the growth curve of Lactobacillus sp. in the homogenized extract of Isochrysis sp.; the curve 15 is the growth curve of Lactobacillus sp.
  • the curve 16 is the growth curve of Lactobacillus sp. in the entire extract of Isochrysis sp. sterilized in an autoclave
  • the curve 17 is the growth curve of Lactobacillus sp. in the entire extract of Isochrysis sp., sterilized in an autoclave with the addition of 5 grams of glucose per litre of physiological solution
  • the curve 18 is the growth curve of Lactobacillus sp.
  • the curve 19 is the growth curve of Lactobacillus sp. in the extract of Isochrysis sp., homogenized and sterilized in an autoclave with the addition of 5 grams of glucose per litre of physiological solution.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Nutrition Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Method of culture of an anaerobic bacterium, obligate or facultative, in particular Lactobacillus sp., which comprises the inoculation of the anaerobic bacteria in an extract, homogenized or entire, of the unicellular microalgae in a solvent medium under anaerobic conditions. The unicellular microalgae have a concentration in the solvent medium able to sustain the growth of the anaerobic bacteria. With this method, a fermented comprising both a bacterial culture medium and a bacterial population grown in it is obtainable. The fermented is suitable to be inserted into the composition of a constituent source of a bacterium, in particular a probiotic, and, at the same time, of a fermented, in particular rich in omega - 3, for the growth of it, for nutritional, therapeutic and cosmetic use; in particular it can be used as a food supplement.

Description

ANAEROBIC GROWTH OF BACTERIA IN UNICELLULAR ALGA The present invention relates to a novel method for microbiological culture. More particularly, the present invention relates to a method of culture of a probiotic anaerobic bacterium, both obligate and facultative in unicellular algae, with a high nutritional value for human supply, in particular rich in omega-3. Nowadays probiotics based on different bacterial strains are available on the market (generally Lactobacilli or Bifidobacteria) . These probiotics produce lactic acid by fermentation of sugars, in different formulations and concentrations. The beneficial properties of lactic acid are widely recognized, some closely related with bowel health, through the edit action of the intestinal flora.
The positive effects of fermented foods (e.g. Yogurt, cheese) on the human organism have been known for a long time. Moreover, the nutritional qualities of different unicellular algae are also known (eg. Spirulina, Chlorella, Dunaniella) . These algae are rich in protein, minerals and trace elements and they are already greatly appreciated as supplements in the human diet.
Some of these algae are particularly rich in polyunsaturated fatty acids called omega-3, which make them particularly interesting, as the 00158 beneficial and curative properties of omega-3 are scientifically proven.
However, despite the known health benefits of probiotics and omega-3, nowadays, a product containing probiotic bacteria grown in unicellular algae rich in omega-3 doesn't exist on the market.
The present invention aims to provide a product that combines the beneficial properties of probiotics and the ones of unicellular algae rich in omega-3 fatty acids. Specifically, the present invention arises the purpose of providing a product based on probiotic strains grown in unicellular algae rich in omega - 3 which combines the beneficial properties of the cultivated probiotics with the omega - 3 fatty acids .
More in general, the present invention aims to provide a product suitable to constitute the source of probiotic bacteria grown under anaerobic conditions (fermentation) in a culture medium, based on unicellular algae rich in omega - 3, which is suitable for the growing of bacterial strains and, at the end of the bacterial culture, it must not be removed because it provides an important contribution to the human diet, as a source of omega - 3.
It should be emphasized that this preparation has nutritional value (since the probiotic, during the fermentation time, consumes the glucose component of a unicellular alga, leaving unchanged the lipid portion rich in omega-3 available to the human consumption) and therapeutic (both the curative effects of the probiotic and the anti inflammatory and anti - oxidant of the omega - 3 are known) and cosmetic properties (different probiotic strains produce metabolites of glycerin and other moisturizing , ions and heavy metals, where Λ bacterial metabolite ' means any molecule of neo-synthesis that is metabolized by a bacterium, which is economically interesting and obtained by anaerobic growth) .
The Inventors have found that an homogenized unicellular microalgae, either encapsulated or free of the capsule, is accessible from a bacterium, which is able to grow inside it in anaerobic conditions. Thus, the aforementioned objectives are achieved with a method of culture of an anaerobic bacterium both obligate or facultative, which is inoculated in a homogenised or entire extract of unicellular microalgae in a solvent under anaerobic conditions; the unicellular microalgae has a concentration in the solvent able to sustain the growth of the anaerobic bacteria. The present invention possibly involves the further addition of a complement of sugar to the extract of unicellular microalgae in the method of culture of the anaerobic bacteria. The method presented in this invention is economically advantageous and useful for the activation of the metabolism of the anaerobic bacterium and for its tropism in the intestinal lumen.
Moreover, the method makes superfluous each subsequent purification step of the bacterium from its growth medium, which in turn has an important nutritional value in the lipid content and therapeutic properties due to the presence of omega - 3.
Differently to what has been done so far in the use of unicellular algae with industrial purposes, for example as biofuels, or cosmetic, the approach of the present invention does not contain any extraction of the organic phase or enrichment of the lipid phase. The microalga is used in its entirety, since the component of sugar and protein is functional to the growth of the bacterium, while the lipid portion is maintained as a source of omega - 3 fatty acids in the final fermented product .
As explained above, in the present invention it is contemplated that, for the method of culture of an anaerobic probiotic bacterium, the extract of single-cell microalgae is an extract of Nannochloropsis gaditana homogenized and, in particular, that the extract of Nannochloropsis gaditana has been obtained starting from a fresh culture of Nannochloropsis gaditana in the exponential phase of growth.
It is also contemplated that in the method of culture of an anaerobic bacterium according to the present invention, as described above, the single- cell microalgae extract is an extract of Isochrysis sp. And, more particularly, that the extract of Isochrysis sp. has been obtained from Isochrysis sp. lyophilized. A product containing a fermented is so obtained, comprising in combination both a bacterial culture medium and a bacterial population grown in it, obtained by the method of culture of an anaerobic bacterium as described above, for which the product is suitable as source of probiotic and simultaneously as source of a fermented of the unicellular alga containing omega- 3 for nutritional, therapeutic or cosmetic use.
Moreover, in the present invention it is contemplated that, in the method of culture of an anaerobic bacterium, as described above, Lactobacillus sp. is the inoculated anaerobic bacterium. A product containing an entire fermented is so obtained as described above, wherein the anaerobic bacterium is Lactobacillus sp., for which the product is suitable as a source of probiotic and, at the same time, as a dietary supplement of the fermented of algae, rich in omega - 3, used for the growth of the bacterium. Thus, the present invention defines a culture technique of obligate or facultative anaerobic bacteria, which does not resort to the microbiological culture media available on the market, and uses an entire or homogenate extract of single-cell microalgae in oxygen-free conditions as the sole source of proliferation of the bacteria.
The fermented product obtained with the method of the present invention is completely free of animal elements, respect to probiotics grown in classical culture broths, containing extracts of lean meat, rich in amino acids, peptides, nucleotides, organic acids, vitamins and minerals. Therefore, a method of culture of an anaerobic bacterium, obligate or facultative, as recited in Claim 1 attached hereto, constitutes the object of the present invention.
In addition, object of the present invention is also a method of culture of an anaerobic bacterium, obligate or facultative, as recited in Claim 2 attached hereto. Preferred examples of this method are recited in the dependent claims 3; 4; 5 ; 6, e 7. Object of the present invention is also a product containing an entire fermented, comprising in combination both a medium of bacterial culture and a bacterial population grown in it, as recited in the attached claim 8. A preferred example of this method is recited in the attached dependent claims 9. The present invention will be fully understood based on the following detailed description of the best way of implementing it, given only as example, absolutely not limitative of the invention itself, in reference to the attached drawings, in which:
- FIG 1 is a diagram which shows the curves of bacterial growth under anaerobic conditions in an extract of a first strain of the unicellular alga in a bacterial culture according to the method of the present invention and in a culture media commercially available, and
- FIGURE 2 is a diagram showing the curves of bacterial growth under anaerobic conditions in an extract of a second strain of the unicellular alga in a bacterial culture according to the method of the present invention and in a culture medium commercially available.
The present invention is a method of culture of an anaerobic bacterium, obligate or facultative, that inoculates anaerobic bacteria in a homogenate or entire extract of the unicellular alga in a solvent under anaerobic conditions. The concentration of the unicellular alga in the solvent has to be effective to sustain the growth of anaerobic bacteria.
It is contemplated to add a complement of sugars to the extract of single-celled algae.
EXAMPLE I
In this Example I, the extract of unicellular algae is an homogenized extract of Nannochloropsis gaditana and the anaerobic bacterium, from the strain Lactobacillus sp..
Nannochloropsis gaditana is a spheroidal microalgae of diameter about 2 - 3 micrometers, devoid of motor structures. Its lipid content is about 30% of its dry weight. It accumulates large concentrations of various pigments, such as, for example, astaxanthin, canthaxanthin and zeaxanthin. Nannochloropsis gaditana is also a food product and, indeed, it is used to produce dietary- supplements. It is also served at the restaurant in Spain in El Puerto de Santa Maria in Cadiz, in the area where it was isolated for the first time and where it still grows wild. For Nannochloropsis gaditana the bioavailable sugars were measured in the laboratory by the Inventors and result to be dependent on the lysis method of microalgae and constitute from 4 % to 8 % of microalgae dry mass, distributed as follows: from 40% to 50 % of glucose; from 18% to 23 % of galactose; from 13% to from 2% to 4 % of xylose ; from 3% to 5 % of ribose ; from 4 % to 8 % other sugars .
In the present example the extract Nannochloropsis gaditana may have been obtained from a fresh culture of Nannochloropsis gaditana in exponential phase of growth, and the micro-algae of the strain of Nannochloropsis gaditana was subjected to a mechanical homogenization process via a probe homogenizer with teflon head, by homogenization of 2 minutes at 14,000 rounds per minute. Since the purpose of the extract of mxcroalga was to sustain the growth of the bacteria in the anaerobic fermentation conditions, the parameter for the choice of the concentration of microalgae in physiological saline solution was determined based on obtaining an amount of sugar comparable with that described in the literature as sufficient to maintain fermentative metabolism of Lactobacillus sp., that is 10 grams per liter. In order to not compromise the isotonicity of the culture medium, the amount of 100 grams of dry mass per liter of physiological solution it was never exceeded.
The concentration of extract of Nannochloropsis gaditana was less than 10 grams per litre. With this dilution the Inventors verified the growth with the extract of algae, but also with an addition of a complement of 5 grams of glucose per liter and with a culture medium MRS DE MAN - ROGOSA - SHARPE for lactobacilli , commercially available. In the exposed experiment a sterility control of the culture medium and of the extract of microalgae was included. Under the experimental conditions of Example I, the growth took place into sealed tubes, in fact, any induced correction of the acidity produced by lactic acid fermentation was not expected, it was therefore expected that the fermentation was stopped because of the acidification of the culture medium and because of sugar depletion.
The results of the growth of Lactobacillus sp. in the extract of Nannochloropsis gaditana, fresh and homogenized, are illustrated in FIGURE 1, in which: the curve 1 is the growth curve obtained with the commercially available MRS culture medium; the curve 2 is the growth curve of Lactobacillus sp. in the extract of Nannochloropsis gaditana (homogenized) ; curve 3 is the growth curve of Lactobacillus sp. in the extract of Nannochloropsis gaditana (homogenized) with the addition of 5 grams of glucose per liter of physiological solution. Surprisingly the inventors revealed that, in the aforementioned experimental conditions, the suitably homogenized extract of Nannochloropsis gaditana was able to support the growth of Lactobacillus sp. without the aid of any sugar integration, even if an addition of sugar sensibly improves the yield, at least for three days starting from the inoculation of the bacterium.
EXAMPLE II
In the Example II the extract of unicellular microalgae is an extract of Isochrysis sp. and the strain of the anaerobic bacterium is Lactobacillus sp.. Isochrysis sp. is a brown and flagellated unicellular alga, about 5 micrometers long and widely used in aquaculture. It has a high content of docosahexaenoic acid or DHA (omega - 3 fatty acid is the most effectively under the curative profile) and Isochrysis sp. is often used to enrich zooplankton (rotifers or Artemia) . It is considered a primary algae and it is the most commonly used to raise oysters, clams, mussels, scallops and in the shellfish farms. The high content of omega3 and sugar (about 30% of the dry weight) of Isochrysis sp., in addition to the absence of a cellulose capsule, makes Isochrysis sp. particularly suitable for the purposes of the present invention. The advantage of Isochrysis sp. is to have a high content of sugars and not to possess a cellulose capsule. This latter feature ensures that it is accessible to a bacterium and that is able to ensure the growth also in a non-homogenized state. On the contrary an encapsulated microalga is of difficult access for a bacterium and therefore the culture is not possible without prior homogenization. In this Example II the extract of Isochrysis sp. was obtained from Isochrysis sp. lyophilized. Even under the experimental conditions of Example II the growth took place in sealed tubes in such a way that the application of any induced correction of acidity produced by lactic acid fermentation was not expected. It was therefore expected that the fermentation was stopped by the acidification of the culture medium and cause of sugar depletion.
The results of the growth of Lactobacillus sp. in Isochrysis sp . extract are illustrated in FIGURE 2, in which: the curve 11 is the growth curve obtained with the commercially available MRS culture medium; the curve 12 is the growth curve of Lactobacillus sp. in the entire extract of Isochrysis sp.; the curve 13 is the growth curve of Lactobacillus sp. in the entire extract of Isochrysis sp., with the addition of 5 grams of glucose per litre of physiological solution; the curve 14 is the growth curve of Lactobacillus sp. in the homogenized extract of Isochrysis sp.; the curve 15 is the growth curve of Lactobacillus sp. in the homogenized extract of Isochrysis sp. with the addition of 5 grams of glucose per litre of physiological solution; the curve 16 is the growth curve of Lactobacillus sp. in the entire extract of Isochrysis sp. sterilized in an autoclave; the curve 17 is the growth curve of Lactobacillus sp. in the entire extract of Isochrysis sp., sterilized in an autoclave with the addition of 5 grams of glucose per litre of physiological solution ; the curve 18 is the growth curve of Lactobacillus sp. in the extract of Isochrysis s ., homogenized and sterilized in an autoclave, and the curve 19 is the growth curve of Lactobacillus sp. in the extract of Isochrysis sp., homogenized and sterilized in an autoclave with the addition of 5 grams of glucose per litre of physiological solution.
The speed of growth of Lactobacillus sp. in the extract of Isochrysis sp. was higher from the first day of inoculation of the bacterium and it wasn't noticeable any advantage with the addition of 5 grams per liter of glucose. The bioavailable sugars were sufficient to ensure the growth of Lactobacillus sp. until at least 4 days after inoculation of this . The present invention has been shown in reference to specific examples thereof, but it must be expressly understood that variations may be made thereto without departing from the scope of the appended claims .

Claims

CLAIMS :
Method of culture of anaerobic bacteria, obligate or facultative, that provides the inoculation of the anaerobic bacteria in an extract, homogenate or entire, of unicellular algae rich in omega - 3 in a solvent under anaerobic conditions. Unicellular microalgae must have a concentration in the solvent, suitable to support the growth of the anaerobic bacteria .
Method of culture of an anaerobic bacterium as claimed in claim 1, further comprising the addition of a complement of sugars to the aforementioned extract of unicellular microalga.
Method of culture as claimed in claim 1 or 2, which also makes unnecessary any subsequent purification step of the bacteria from the growth medium, which in turn has an important nutritional value in lipid content and therapeutic properties due to the presence of omega - 3.
Method of culture of an anaerobic bacterium as claimed in any Claims from 1 to 3 , wherein the mentioned extract is an extract of homogenized unicellular microalgae Nannochloropsis gaditana . Method of culture of an anaerobic bacterium as claimed in claim 4, wherein the mentioned extract of Nannochloropsis gaditana was obtained from a fresh culture of Nannochloropsis gaditana in exponential phase of growth .
Method of culture of an anaerobic bacterium as claimed in claim 1, wherein the mentioned unicellular algae extract is an extract of Isochrysis sp .
Method of culture of an anaerobic bacterium as claimed in claim 6, wherein the mentioned extract of Isochrysis sp . was obtained from Isochrysis sp . lyophilized.
Method of culture of an anaerobic bacterium as claimed in any Claims from 1 to 7 , wherein the mentioned anaerobic bacterium is Lactobacillus sp..
A product containing an entire fermented, comprising in combination both a medium of bacterial culture and a bacterial population grew in it. This is obtained by the method of culture of an anaerobic bacterium, obligate or facultative, as claimed in any Claims from 1 to 7, for which the product is suitable as a source of probiotic and at the same time of the fermented of algae for the growth of these, for nutritional, therapeutic or cosmetic use.
10. Product containing an entire fermented as claimed in claim 9, wherein the mentioned anaerobic bacterium is Lactobacillus sp.. The product is suitable as a source of probiotic and at the same time of the fermented of algae for the growth of the probiotic. This product can be used as a food supplement .
11. Product based on probiotic strains grown in unicellular algae rich in omega - 3 as claimed in any Claims from 1 to 7 which then combine the beneficial properties of the probiotics cultivated and omega - 3 fatty- acids .
PCT/IT2016/000158 2016-06-17 2016-06-17 Anaerobic growth of bacteria in unicellular alga WO2017216818A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/IT2016/000158 WO2017216818A1 (en) 2016-06-17 2016-06-17 Anaerobic growth of bacteria in unicellular alga

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2016/000158 WO2017216818A1 (en) 2016-06-17 2016-06-17 Anaerobic growth of bacteria in unicellular alga

Publications (1)

Publication Number Publication Date
WO2017216818A1 true WO2017216818A1 (en) 2017-12-21

Family

ID=56855772

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IT2016/000158 WO2017216818A1 (en) 2016-06-17 2016-06-17 Anaerobic growth of bacteria in unicellular alga

Country Status (1)

Country Link
WO (1) WO2017216818A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201800005108A1 (en) * 2018-05-07 2019-11-07 PROCEDURE FOR THE SYNTHESIS OF SILVER NANOPARTICLES BY MEANS OF PROBIOTIC STRAINS GROWN IN ALGAE, NANOPARTICLES SO OBTAINED AND RELATED USES

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006112364A1 (en) * 2005-04-15 2006-10-26 Dainippon Ink And Chemicals, Inc. Hypotensive agent produced by cultivation of lactic acid bacterium
US20140127761A1 (en) * 2011-07-14 2014-05-08 Ajinomoto Co., Inc. Method for Producing Fatty Acid

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006112364A1 (en) * 2005-04-15 2006-10-26 Dainippon Ink And Chemicals, Inc. Hypotensive agent produced by cultivation of lactic acid bacterium
US20140127761A1 (en) * 2011-07-14 2014-05-08 Ajinomoto Co., Inc. Method for Producing Fatty Acid

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 200706, 2007 Derwent World Patents Index; AN 2007-056263, XP002767591 *
MD. MAHABUBUR RAHMAN TALUKDER ET AL: "Microalgae (Nannochloropsis salina) biomass to lactic acid and lipid", BIOCHEMICAL ENGINEERING JOURNAL, vol. 68, 1 October 2012 (2012-10-01), pages 109 - 113, XP055140782, ISSN: 1369-703X, DOI: 10.1016/j.bej.2012.07.001 *
RYCKEBOSCH ELINE ET AL: "Nutritional evaluation of microalgae oils rich in omega-3 long chain polyunsaturated fatty acids as an alternative for fish oil", FOOD CHEMISTRY, vol. 160, 2014, pages 393 - 400, XP028660381, ISSN: 0308-8146, DOI: 10.1016/J.FOODCHEM.2014.03.087 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201800005108A1 (en) * 2018-05-07 2019-11-07 PROCEDURE FOR THE SYNTHESIS OF SILVER NANOPARTICLES BY MEANS OF PROBIOTIC STRAINS GROWN IN ALGAE, NANOPARTICLES SO OBTAINED AND RELATED USES
EP3567114A1 (en) * 2018-05-07 2019-11-13 OCEAN FARMA S.r.l Process for the synthesis of silver nanoparticles using probiotic strains grown in algae, ternary mixture thus obtained and uses thereof

Similar Documents

Publication Publication Date Title
Beheshtipour et al. Supplementation of Spirulina platensis and Chlorella vulgaris algae into probiotic fermented milks
Iwamoto Industrial production of microalgal cell‐mass and secondary products‐major industrial species: chlorella
CN103109930B (en) Fruity probiotic yogurt slice containing antifreeze sericin peptide and method for preparing same
CN106399163B (en) A kind of anti-aging probiotics preparation and preparation method
CN102271535B (en) Sialic acid producing bacteria
JP2008136493A (en) Method for production of arachidonic acid
CA2675691A1 (en) Methods for producing polyunsaturated fatty acid and lipid containing polyunsaturated fatty acid
KR101921475B1 (en) Method for manufacturing functional fermented material of Spirulia by lactic acid fermentation or yeast fermentation
AU2021202832B2 (en) Repeated fed-batch culture methods
WO2015063282A1 (en) Use of algae to increase the viable active biomass of lactic acid bacteria
KR102236782B1 (en) Methods of oil production in microorganisms
WO2017216818A1 (en) Anaerobic growth of bacteria in unicellular alga
JP6330237B2 (en) Lactobacillus lactic acid bacteria culture-grade culture medium, Lactobacillus lactic acid bacteria culture method, and Lactobacillus lactic acid bacteria culture production method
JP6429162B1 (en) Labyrinthula culture method
CN106399407B (en) Utilize the method for acer truncatum buge oil Efficient Conversion preparation conjugated linoleic acid
AU2005302793A1 (en) Process for preparing a bacterial culture, and the product prepared by the process
WO2023140321A1 (en) Novel organism breeding technique
US20230235371A1 (en) Method for culturing microorganisms for lipid accumulation
RU2541778C2 (en) Method for production of bacterial concentrate and its application as probiotic biologically active food additive
AMIRKHANOVA et al. BULLETIN OF THE KARAGANDA UNIVERSITY. BIOLOGY. MEDICINE. GEOGRAPHY SERIES
Abdulrahman et al. IN-VITROCONJUGATED-LINOLEIC-ACID-FORMATION-BY-NEWLY-ISOLATED-ANAEROBIC-GUT-FUNGI
Paliy et al. Influence of various prebiotic components on the main growth indicators of probiotic bacteria
KR20240026429A (en) Novel Schizochytrium sp. strain producing a biomass containing high protein content, antioxidant pigments and omega-3 fatty acid and uses thereof
Liu et al. Proliferation of probiotics and antioxidant effects of functional oligosaccharides added in fermented dairy product

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16760561

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16760561

Country of ref document: EP

Kind code of ref document: A1